A truckload of data will hit markets in the coming week, but it's the jobs report Friday when Wall Street is closed that will be the most important.» Read More
Big pharmaceutical stocks are on the move today amid the annual ASCO conference, says CNBC's Barbara Ryan.
Bristol-Myers reached a new 52-week high in today's trading, with the "Fast Money" traders; and David Magee, Suntrust Robinson Humphrey discusses the big boost for Best Buy's stock.
What to watch for in tomorrow's markets, with Jim Kee, South Texas Money Management and Samuel Coffin, UBS Macro Research.
Stocks will continue to rise for the next two years until the wealth gap between Wall Street and Main Street gets too high, economist Nouriel Roubini told CNBC.
CNBC's Sharon Epperson discusses the day's activity in the commodities markets. A major oil outage in the North Sea could impact oil prices. And a lot of shorts in the gold market are causing prices to rise.
CNBC's Josh Lipton looks at three stocks to watch tomorrow, including Dollar General, which reports tomorrow before the bell. Also, Deutsche Bank holds its financial services conference tomorrow, and after the bell, Tesla holds its annual shareholder meeting.
Discussing where the markets may be headed, with Larry Glazer, Mayflower Advisors; Jeffrey Saut, Raymond James; Chris Gersch, Altimus Capital; and Warren Meyers, DME Securities.
CNBC's Sharon Epperson reports that Barclays says gold shorts have hit a record high and could rise further.
Michael Yoshikami, Destination Wealth Management, takes a look at the latest analyst calls.
The FMHR traders reveal their final trades of the hour.
CNBC's Simon Hobbs reports shares traded lower across Europe, despite an improvement in factory data.
CNBC's Eamon Javers reports there's a correction between rising amounts of e-mail spam and the stock market.
The "Squawk on the Street" news team reports on today's top business headlines, including a look at June, as the markets kick off another month; and a look at how positive news on several promising cancer drugs are impacting big pharma stocks.
Don't start your trading day without finding out what CNBC's Jim Cramer is watching ahead of the opening bell.
The bull case for stocks remains intact, despite their worst one-day declines in about seven weeks, Thomas Lee, chief U.S. equity strategist at JPMorgan, tells CNBC.
Michael Ryan, UBS Wealth Management, provides a preview of Friday's jobs report. And, Larry Bossidy, former Honeywell chairman & CEO explains why investors need to make the distinction between Fed "tapering" and "tightening."
Lawrence Bossidy, former Honeywell chairman& CEO, provides his views on when and how the Fed's tapering program should begin.
Michelle Girard, RBS chief economist, and Nariman Behravesh, IHS chief economist, weigh in on how the markets are likely to react to the Fed's tapering program and provide a preview of Friday's employment report.
Thomas Lee, JPMorgan chief U.S. equity strategist, explains why the market's "underlying bullish story" is still sound despite rising rates.
CNBC's Ross Westgate tells you what the markets will be watching as we approach the start of trading in the U.S.